日本薬局方（JP）130 周年記念シンポジウムと JP18 に向けた今後の課題

DOI Web Site
  • 伹野 恭一
    独立行政法人医薬品医療機器総合機構規格基準部
  • 酒井 喜代志
    独立行政法人医薬品医療機器総合機構規格基準部
  • 宮崎 生子
    独立行政法人医薬品医療機器総合機構規格基準部

書誌事項

タイトル別名
  • Japanese Pharmacopoeia (JP) 130th Anniversary Symposium and Future Efforts for the Next Major Revised Version, JP18
  • ニホン ヤッキョクカタ(JP)130シュウネン キネン シンポジウム ト JP18 ニ ムケタ コンゴ ノ カダイ

この論文をさがす

説明

The first edition of Japanese Pharmacopoeia (JP), which is a normative public document containing specifications and standards on pharmaceutical quality and standard test methods, was promulgated in June 1886. After being published, it continued to be revised to include the latest scientific knowledge of that era. In March 2016, the 17th revised Japanese Pharmacopoeia (JP17) was introduced and promulgated. In September 2016, to mark the 130th anniversary of the establishment of JP, as well as publication of the Japanese Pharmacopoeia 17th edition, the Japanese Pharmacopoeia 130th Anniversary Symposium - Challenges for the future- was held in Tokyo, hosted by the Ministry of Health, Labor and Welfare and the Pharmaceuticals and Medical Devices Agency. In this article, we review the past history and background of Japanese Pharmacopoeia, and describe the contents and results of the 130th Anniversary Symposium. In addition, we explain the Five Pillars for Revision described in the basic policies for preparation of the next major revised edition, JP18, and also consider future issues required for formulating JP18.

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ